Reliability and validity of the SF-36 in HIV-infected homeless and marginally housed individuals

Quality of Life Research

Volumn 12, Issue 8, 2003, Pages 1051-1058

  Riley, E D ^a   Bangsberg, D R ^a   Perry, S ^b   Clark, R A ^b   Moss, A R ^b   Wu, A W ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Health status; HIV; Homeless; Reliability; Short form 36 (SF 36); Validity

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEALTH STATUS; HEALTH SURVEY; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; SHORT FORM 36; VIRUS INFECTION; VIRUS LOAD;

ADULT; FEMALE; HEALTH STATUS INDICATORS; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; UNITED STATES;

EID: 0042562406     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026166021386     Document Type: Article

References (30)

1. Continuum of Care, A 5-Year Strategic Plan for Homeless Services 2001-2006 in the City and County of San Francisco. San Francisco, CA: Mayor's Office on Homelessness, 2001.
2. Gallagher TC, Andersen RM, Koegel P, Gelberg L. Determinants of regular source of care among homeless adults in Los Angeles. Med Care 1997; 35: 814-830.
3. Ferenchick GS. Medical problems of homeless and non-homeless persons attending an inner-city clinic: A comparative study. Am J Med Sci 1991; 301: 379-382.
4. Zolopa AR, Hahn JA, Gorter R, et al. HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA 1994; 272: 455-461.
5. Hwang SW, Orav EJ, O'Connell JJ, Lebow JM, Brennan TA. Causes of death in homeless adults in Boston. Ann Int Med 1997; 126: 625-628.
6. Hibbs J, Benner L, Klugman L, et al. Mortality in a cohort of homeless adults in Philadelphia. N Engl J Med 1994; 331: 304-309.
7. Barrow SM, Herman DB, Córdova P, Struening EL. Mortality among homeless shelter residents in New York City. Am J Public Health 1999; 89: 529-534.
8. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study [see comments]. Br Med J (Clinical Research Ed.) 1997; 315: 1194-1199.
9. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352: 1725-1730.
10. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. (Comment in: N Engl J Med 1998; 339(6): 405-406; comment in: N Engl J Med 1998; 338(13): 906-908). N Engl J Med 1998; 338: 853-860.
11. CDC. US Department of Health and Human Services HIV AIDS Surveillance Report, 1999.
12. Bangsberg D, Charlebois E, Perry S, Robertson M, Osmond D, Moss A. Adherence and AIDS-Free Survival: Findings from the REACH Cohort. 13th International AIDS Conference. Durban, South Africa 2000.
13. Ware JE. The status of health assessment 1994. Ann Rev Public Health 1995; 16: 327-354.
14. Idler EL, Russell LB, Davis D. Survival, functional limitations, and self-rated health in the NHANES I Epidemiologic Follow-up Study, 1992. First National Health and Nutrition Examination Survey. Am J Epidemiol 2000; 152: 874-883.
15. Mossey J, Shapiro E. Self-rated health: A predictor of mortality among the elderly. Am J Public Health 1982; 72: 800-808.
16. Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res 1997; 6: 531-554.
17. Saah AJ, Hoover DR, Weng S, et al. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study. AIDS 1998; 12: 2107-2113.
18. Ruiz L, Romeu J, Clotet B, et al. Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300 × 10(6)/1. AIDS 1996; 10: F39-F44.
19. Beck AT, Steer RA, Brown GK. BDI-II Manual. 2ed. San Antonio, TX: The Psychological Corporation, Harcourt Brace and Company, 1996.
20. Alloy LB, Abramson LY, Whitehouse WG, et al. Depressogenic cognitive styles: Predictive validity, information processing and personality characteristics, and developmental origins. Behaviour Res Therapy 1999; 37: 503-531.
21. Dunn G, Sham P, Hand D. Statistics and the nature of depression. Psychol Med 1993; 23: 871-889.
22. Egelko S, Galanter M, Dermatis H, et al. Improved psychological status in a modified therapeutic community for homeless MICA men. J Addict Dis 2002; 21: 75-92.
23. Callahan EJ, Bertakis KD, Azari R, Helms LJ, Robbins J, Miller J. Depression in primary care: Patient factors that influence recognition. Fam Med 1997; 29: 172-176.
24. Ware JE Jr, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: The IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 945-952.
25. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. 2ed. Lincoln, RI: QualityMetric, Inc. and The Health Assessment Lab, 2000.
26. Wagner AK, Gandek B, Aaronson NK, et al. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 925-932.
27. Bangsberg DR PS, Charlebois ED, Karasic DH, et al. Depression Symptoms (DS) Predict HAART Adherence, Duration, Unstructured Treatment Interruption, and Viral Suppression. 41st ICAAC, Chicago 2001.
28. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001; 15: 1181-1183.
29. Ware JE Jr, Bjorner JB, Kosinski M. Practical implications of item response theory and computerized adaptive testing: A brief summary of ongoing studies of widely used headache impact scales. (Comment on: Med Care 2000; 38(9 Suppl): II28-II42 comment on: Med Care 2000; 38(9 Suppl): II43-II59]. Med Care 2000; 38: II73-II82.
30. Hays RD, Morales LS, Reise SP. Item response theory and health outcomes measurement in the 21st century (see comments). Med Care 2000; 38: II28-II42.